Bot Detector
Download FREE Sample Issue or Article
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Compounding for the Effects of Weapons of Mass Destruction

Author(s):  Sammarco Domenic A

Issue:  Jan/Feb 2003 - Terrorism
View All Articles in Issue

Page(s):  10-15

Compounding for the Effects of Weapons of Mass Destruction Page 1
Compounding for the Effects of Weapons of Mass Destruction Page 2
Compounding for the Effects of Weapons of Mass Destruction Page 3
Compounding for the Effects of Weapons of Mass Destruction Page 4
Compounding for the Effects of Weapons of Mass Destruction Page 5
Compounding for the Effects of Weapons of Mass Destruction Page 6

Download in electronic PDF format for $75

Abstract:  As incidents of terrorism become more common, pharmacists and medical professionals must plan for a possible domestic terrorist attack involving biologic, chemical or nuclear weapons. For the United States to be truly prepared, federal, state and local agencies must have the knowledge, intelligence, training and supplies to counter this realistic threat of the 21st century. Terrorists often use chemical, biologic or limited nuclear warfare involving weapons that are easier to produce and smaller in size and that have a profound psychological and physical impact.

Related Keywords: Anthrax, prophylaxis against, Biologic agents of war, prophylaxis against, Biologic warfare, prophylaxis against, Blister agents, prophylaxis against, Blood agents, prophylaxis against, Botulism, prophylaxis against, Brucellosis, prophylaxis against, Chelating agents, radionuclide, for exposure to radiologic agents of war, Chemical agents of war, prophylaxis against, Chemical warfare, prophylaxis against, Cholera, prophylaxis against, Cyanide, prophylaxis against, Disaster plan, community, for biologic or chemical warfare, Encephalitides, viral, prophylaxis against, Glanders, prophylaxis against, Hemorrhagic fevers, viral, prophylaxis against, Lung agents, prophylaxis against, Nerve agents, prophylaxis against, Nuclear warfare agents, prophylaxis against, Plague, prophylaxis against, Q fever, prophylaxis against, Radiologic agents, prophylaxis against and treatment for, Ricin, prophylaxis against, Smallpox, prophylaxis against, Staphylococcus enterotoxin B, prophylaxis against, T-2 mycotoxins, prophylaxis against, Tularemia, prophylaxis against, Warfare, agents of, prophylaxis against, Warfare, biologic, prophylaxis against, Warfare, chemical, prophylaxis against, Warfare, vaccines for use in, Weapons of mass destruction, resources for counteracting, Terrorism


Printer-Friendly Version

Related Articles from IJPC
(Click for Abstract / Details / Purchase)
Compounding for the Effects of Weapons of Mass Destruction
Sammarco Domenic A
Jan/Feb 2003
Pg. 10-15

View Sample
Prophylaxis Against Exposure to Bloodborne Pathogens During Compounding
Williams Angie
, Mixon William
Jan/Feb 2010
Pg. 14-18

Wetting and/or Solubilizing Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 2001
Pg. 310-312

Prophylaxis Against Heartworm Infection and Flea or Tick Infestation in Dogs: Single Agents and Combination-Drug Products
Riepl Mike
May/Jun 2024
Pg. 205-213

Basics of Compounding for Terrorist Attacks, Part 2
Allen Loyd V Jr
Mar/Apr 2003
Pg. 129-134

View Sample
Estradiol: The Emerging Evidence for a Protective Role Against Insulin Resistance and Obesity
Biundo Bruce
, Gogola Margaret
Jul/Aug 2015
Pg. 289-293

Featured Excipient: Disinfecting Agents
Allen Loyd V Jr
Nov/Dec 2002
Pg. 462-464

Basics: Excipients Used in Nonsterile Compounding, Part 6: Compounding with Viscosity-increasing Agents
Allen Loyd V Jr
May/Jun 2020
Pg. 206-212

Compounding for the Treatment of COVID-19 and Long COVID, Part 5: Associated Conditions, Prophylaxis, and Effective Treatment
Riepl Mike
, Kaiser Joe
Sep/Oct 2023
Pg. 368-380

Basics: Excipients Used in Nonsterile Compounding, Part 4: Antioxidants and Chelating Agents
Allen Loyd V Jr
Jan/Feb 2020
Pg. 38-43

A Compendium of Compounding Agents and Formulations, Part 4: Nifedipine and Pentoxifylline
Riepl Mike
Jul/Aug 2022
Pg. 270-274

Acidifying Agents, Featured Excipient:
Allen Loyd V Jr
Jul/Aug 1999
Pg. 309-310

Basics of Compounding for Cold Sores or Fever Blisters
Allen Loyd V Jr
May/Jun 2004
Pg. 206-209

Antimicrobial Activity of Copaiba (Copaifera officinalis) and Pracaxi (Pentaclethra macroloba) Oils against Staphylococcus aureus: Importance in Compounding for Wound Care
Guimarães Anna Luísa Aguiar
, Cunha Elisa Alves, Matias Fernanda Oliveira, Garcia Patrícia Guedes, Danopoulos Panagiota, Swikidisa Rosita, Pinheiro Vanessa Alves, Nogueira Rodrigo José Lupatini
Jan/Feb 2016
Pg. 58-62

Evaluation of the Antibacterial Activity of Green Propolis Extract and Meadowsweet Extract Against Staphylococcus aureus Bacteria: Importance in Would Care Compounding Preparations
Lupatini Nogueira Rodrigo José
, Danopoulos Panagiota, Swikidisa Rosita, Alves Pinheiro Vanessa
Jul/Aug 2016
Pg. 333-337

Compatibility of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid
Chuong Monica
, Taglieri Catherine A, Huang Szu Yu, Sariol Anthony, Kitigawa Reina, Barman Koushik, Mistry Amee, Harris Donna L, Kerr Stephen G
Nov/Dec 2019
Pg. 504-510

The Use of Psychoactive Agents in Veterinary Medicine
Simpson Barbara S
Mar/Apr 2001
Pg. 86-88

Heartworm-, Flea-, and Tick-associated Diseases in Dogs: A Review of Common Parasites and Drug Classes Prophylactic Against Them
Riepl Mike
May/Jun 2024
Pg. 188-193

Experimenting with a New Emulsifying Agent (Tahini) in Mineral Oil Emulsion
Al-Achi Antoine
, Greenwood Robert, Akin-Isijola Austin
Jul/Aug 2000
Pg. 315-317

Antineoplastic Agents
Ashworth Lisa D
Jul/Aug 2001
Pg. 268-271

Return to Top